These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 38047596)

  • 1. Cancer Evolution: A Multifaceted Affair.
    Ciriello G; Magnani L; Aitken SJ; Akkari L; Behjati S; Hanahan D; Landau DA; Lopez-Bigas N; Lupiáñez DG; Marine JC; Martin-Villalba A; Natoli G; Obenauf AC; Oricchio E; Scaffidi P; Sottoriva A; Swarbrick A; Tonon G; Vanharanta S; Zuber J
    Cancer Discov; 2024 Jan; 14(1):36-48. PubMed ID: 38047596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Multidimensional Evolutionary Forces to Combat Cancer.
    McCoach CE; Bivona TG
    Cancer Discov; 2019 May; 9(5):587-604. PubMed ID: 30992280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Cancer Progression in the Context of Darwinism.
    Lacina L; Čoma M; Dvořánková B; Kodet O; Melegová N; Gál P; Smetana K
    Anticancer Res; 2019 Jan; 39(1):1-16. PubMed ID: 30591435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.
    Sharma NK; Pal JK
    Curr Mol Med; 2021; 21(3):177-181. PubMed ID: 32436828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.
    Nam AS; Chaligne R; Landau DA
    Nat Rev Genet; 2021 Jan; 22(1):3-18. PubMed ID: 32807900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the ecological and evolutionary dynamics of cancer.
    Zahir N; Sun R; Gallahan D; Gatenby RA; Curtis C
    Nat Genet; 2020 Aug; 52(8):759-767. PubMed ID: 32719518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallmarks of Cancer: New Dimensions.
    Hanahan D
    Cancer Discov; 2022 Jan; 12(1):31-46. PubMed ID: 35022204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
    Lodewijk I; Nunes SP; Henrique R; Jerónimo C; Dueñas M; Paramio JM
    Clin Epigenetics; 2021 Mar; 13(1):63. PubMed ID: 33761971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
    Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular principles of metastasis: a hallmark of cancer revisited.
    Fares J; Fares MY; Khachfe HH; Salhab HA; Fares Y
    Signal Transduct Target Ther; 2020 Mar; 5(1):28. PubMed ID: 32296047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
    Scanlon SE; Glazer PM
    DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy.
    Rath S; Chakraborty D; Pradhan J; Imran Khan M; Dandapat J
    Cytokine; 2022 Sep; 157():155967. PubMed ID: 35905624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
    El-Deiry WS; Taylor B; Neal JW
    Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation-selection balance and compensatory mechanisms in tumour evolution.
    Persi E; Wolf YI; Horn D; Ruppin E; Demichelis F; Gatenby RA; Gillies RJ; Koonin EV
    Nat Rev Genet; 2021 Apr; 22(4):251-262. PubMed ID: 33257848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling the Epigenetic Landscape of the Tumor Microenvironment Using Chromatin Immunoprecipitation Sequencing.
    Fukano M; Alzial G; Lambert R; Deblois G
    Methods Mol Biol; 2023; 2614():313-348. PubMed ID: 36587133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.
    Zhang A; Miao K; Sun H; Deng CX
    Int J Biol Sci; 2022; 18(7):3019-3033. PubMed ID: 35541919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity in cancer stem cells and tumor evolution: Toward precision medicine.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2017 Jun; 44():3-9. PubMed ID: 28254567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microenvironment and molecular biology of the multiple myeloma tumor.
    Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K
    Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.